NovaBridge Biosciences (NBP) Goodwill & Intangibles (2018 - 2023)

NovaBridge Biosciences (NBP) has reported Goodwill & Intangibles for 6 consecutive years, with $16.4 million the latest figure, recorded in Q4 2023.

• Quarterly Goodwill & Intangibles fell 58.55% year-over-year to $16.4 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $16.4 million (down 58.55% YoY) and the FY2023 annual result came in at $16.7 million, down 57.77% from the prior year.
• Goodwill & Intangibles declined to $16.4 million in Q4 2023 per NBP's latest filing, from $40.1 million in the prior quarter.
• Over the last five years, Goodwill & Intangibles for NBP reached as high as $44.1 billion in Q4 2021 and fell as low as $16.4 million in Q4 2023.
• A 5-year average of $4.4 billion and a median of $42.4 million in 2020 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2021 — Goodwill & Intangibles soared 103270.82% — and 2022, when it plunged 99.91%.
• Year by year, Goodwill & Intangibles stood at $44.2 million in 2019, then declined by 3.35% to $42.7 million in 2020, then surged by 103270.82% to $44.1 billion in 2021, then sank by 99.91% to $39.6 million in 2022, then tumbled by 58.55% to $16.4 million in 2023.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $16.4 million, $40.1 million, and $39.6 million for Q4 2023, Q2 2023, and Q4 2022 respectively.